Patents Assigned to Odonate Therapeutics, Inc.
  • DOSING SCHEDULE FOR TESETAXEL AND CAPECITABINE
    Publication number: 20200179427
    Abstract: The present disclosure provides methods for treating a patient with cancer, such as metastatic breast cancer, comprising administering tesetaxel and capecitabine to the patient.
    Type: Application
    Filed: June 1, 2018
    Publication date: June 11, 2020
    Applicant: Odonate Therapeutics, Inc.
    Inventors: Thomas Wei, Kevin Tang, Stew Kroll, John G. Lemkdy, Steven Pfeiffer, Jeff Vacirca